Caveolae Contribute to the Apoptosis Resistance Induced by the α1A-Adrenoceptor in Androgen-Independent Prostate Cancer Cells-Reference-Cited by-同舟云学术

Caveolae Contribute to the Apoptosis Resistance Induced by the α1A-Adrenoceptor in Androgen-Independent Prostate Cancer Cells

Published:2009-09-18 Issue:9 Volume:4 Page:e7068
ISSN:1932-6203
Container-title:PLoS ONE
language:en
Short-container-title:PLoS ONE

Author:

Katsogiannou Maria,Boustany Charbel El,Gackiere Florian,Delcourt Philippe,Athias Anne,Mariot Pascal,Dewailly Etienne,Jouy Nathalie,Lamaze Christophe,Bidaux Gabriel,Mauroy Brigitte,Prevarskaya Natalia,Slomianny Christian

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference75 articles.

1. Global cancer statistics, 2002.;DM Parkin;CA Cancer J Clin,2005

2. Mechanisms involved in the progression of androgen-independent prostate cancers: it is not only the cancer cell's fault.;JT Arnold;Endocr Relat Cancer,2002

3. Apoptosis evasion: the role of survival pathways in prostate cancer progression and therapeutic resistance.;S McKenzie;J Cell Biochem,2006

4. Studies on the structure and intrinsic innervation of the normal human prostate.;JR Higgins;Prostate,1989

5. Alpha 1-adrenoceptor subtypes in the human prostate.;CR Chapple;Br J Urol,1994

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Caveolin-1 and lipids: Association and their dualism in oncogenic regulation;Biochimica et Biophysica Acta (BBA) - Reviews on Cancer;2023-11

2. Idiopathic Pulmonary Fibrosis Molecular Substrates Revealed by Competing Endogenous RNA Regulatory Networks;OMICS: A Journal of Integrative Biology;2023-08-01

3. Comparative effect of sodium butyrate and sodium propionate on proliferation, cell cycle and apoptosis in human breast cancer cells MCF-7;Breast Cancer;2020-02-24

4. The regulatory pathways leading to stem-like cells underlie prostate cancer progression;Asian Journal of Andrology;2019

5. Clinical significance of expression levels of serum ADRA1A in hysterocarcinoma patients;Oncology Letters;2018-04-11